Catalyst Wire Dossier Catalyst Wire Dossier

Selitrectinib

selitrectinib · Bayer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Selitrectinib, covering 2024-10-30 to 2024-10-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer [Phase 1]

See pricing